Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 839-845

  Roch Ramel, Françoise ^a   Guisan, Barbara ^a   Diezi, Jacques ^a  

^a University of Lausanne Departement de Pharmacologie et de Toxicologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; BENZBROMARONE; CHLOROTHIAZIDE; ETHAMBUTOL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOSARTAN; PROBENECID; PYRAZINOIC ACID; SALICYLIC ACID; SULFINPYRAZONE; TIENILIC ACID; URICOSURIC AGENT;

ADULT; AGED; ANION EXCHANGE; ARTICLE; BINDING SITE; BRUSH BORDER; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN TISSUE; KIDNEY TUBULE ABSORPTION; MEMBRANE VESICLE; PRIORITY JOURNAL;

AGED; BENZBROMARONE; BIOLOGICAL TRANSPORT; BIPHENYL COMPOUNDS; CARBON RADIOISOTOPES; DIURETICS; ETHAMBUTOL; HUMANS; IMIDAZOLES; KIDNEY CORTEX; KIDNEY NEOPLASMS; KINETICS; LOSARTAN; MICROVILLI; MIDDLE AGED; PROBENECID; PYRAZINAMIDE; SALICYLIC ACID; SALICYLIC ACIDS; SULFINPYRAZONE; TETRAZOLES; TICRYNAFEN; URIC ACID; URICOSURIC AGENTS;

EID: 0030937113     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. BIBER, J., STIEGER, B., HAASE, W. AND MURER, H.: A high yield preparation for rat kidney brush border membranes. Different behaviour of lysosomal markers. Biochim. Biophys. Acta 647: 169-176, 1981.
2. BROEKHUYSEN, J., PACCO, M., SION, R., DEMEULENAERE, L. AND VAN, H. M.: Metabolism of benzbromarone in man. Eur. J. Clin. Pharmacol. 4: 125-30, 1972.
3. BURNIER, M., ROCH-RAMEL, F. AND BURNIER, H. R.: Renal effect of angiotensin II receptor blockade in normotensive subjects. Kidney Int. 49: 1787-1790, 1996.
4. BURNIER, M., WAEBER, B. AND BRUNNER, H. R.: Clinical pharmacology of the angiotensin ii receptor antagonist losartan potassium in healthy subjects. J. Hypertens. 13: S 23-S 28, 1995.
5. CARR, A. A. AND PRISANT, L. M.: Losartan - first of a new class of angiotensin antagonists for the management of hypertension [Review]. J. Clin. Pharmacol. 36: 3-12, 1996.
6. DAN, T. AND KOGA, H.: Uricosurics inhibit urate transporter in rat renal brush border membrane vesicles. Eur. J. Pharmacol. 187: 303-312, 1990.
7. DE VRIES, J., WALTER-SACK, I., Voss, A., FORSTER, W., ILISISTEGUI, P. P., STOETZER, F., SPRAUL, M., ACKERMANN, M. AND MOYNA, G.: Metabolism of benzbromarone in man: structures of new oxidative metabolites, 6-hydroxy- and 1′-oxo-benzbromarone, and the enantioselective formation and elimination of 1′-hydroxybenzbromarone, Xenobiotica 23: 1435-50, 1993.
8. DIAMOND, H. S.: Uricosuric drugs. In Handbook of Experimental Pharmacology, Vol. 51: Uric Acid, ed. by W. N. Kelley and I. M. Weiner, pp. 459-484, Springer Verlag, New York, 1978.
9. EDWARDS, R. M., TRIZNA, W., STACK, E. J. AND WEINSTOCK, J.: Interaction of nonpeptide angiotensin ii receptor antagonists with the urate transporter in rat renal brush-border membranes. J. Pharmacol. Exp. Ther. 276: 125-129, 1996.
10. EMMERSON, B. T. Abnormal urate excretion associated with renal and systemic disorders, drugs and toxins. In Handbook of Experimental Pharmacology, Vol. 51: Uric Acid, ed. by W. N. Kelley and I. M. Weiner, pp. 211-255, Springer Verlag, New York, 1978.
11. GUGGINO, S. E. AND ARONSON, P. S.: Paradoxical effects of pyrazinoate and nicotinate on urate transport in dog renal microvillus membranes. J. Clin. Invest 76: 543-547, 1985.
12. GUGGINO, S. E., MARTIN, G. J. AND ARONSON, P. S.: Specificity and modes of the anion exchanger in dog renal microvillus membranes. Am. J. Physiol. 244: F612-F621, 1983.
13. GUTMAN, A. B.: Uricosuric drugs, with special reference to probenecid and sulfinpyrazone. Adv. Pharmacol. 4: 91-142, 1966.
14. GUTMAN, A. B., YÜ, T. F. AND BERGER, L.: Tubular secretion of urate in man. J. Clin. Invest. 38: 1778-1781, 1959.
15. KAHN, A. M.: Effect of diuretics on the renal handling of urate. Semin. Nephrol. 8: 305-314, 1988.
16. KAHN, A. M., BRANHAM, S. AND WEINMAN, E. J.: Mechanism of urate and p-aminohippurate transport in rat renal microvillus membrane vesicles. Am. J. Physiol. 245: F151-F158, 1983.
17. MEISEL, A. D. AND DIAMOND, H. S.: Inhibition of probenecid uricosuria by pyrazinamide and para-aminohippurate. Am. J. Physiol. 232: F222-F226, 1977.
18. NAKASHIMA, M., UEMATSU, T., KOSUGE, K. AND KANAMARU, M.: Pilot study of the uricosuric effect of DuP-753, a new angiotensin-II receptor antagonist, in healthy subjects. Eur. J. Clin. Pharmacol. 42: 333-335, 1992.
19. POLKUWSKI, C. A. AND GRASSL, S. M.: Uric acid transport in rat renal basolateral membrane vesicles. Biochim. Biophys. Acta 1146: 145-152, 1993.
20. POSTLETHWAITE, A. E., BARTEL, A. G. AND KELLEY, W. N.: Hyperuricemia due to ethambutol. N. Engl. J. Med 286: 761-762, 1972.
21. ROCH-RAMEL, F. AND DIEZI, J.: Renal transport of organic ions and uric acid. In Diseases of the Kidney, ed. by R. W. Schrier and C. W. Gottschalk, pp. 231-249, Little Brown, Boston, MA, 1997.
22. ROCH-RAMEL, F., GUISAN, B., JAEGER, P. AND DIEZI, J.: Transport of urate and other organic anions by anion-exchange in human brush-border membrane vesicles. Cell Physiol. Biochem., 6: 60-71, 1996a.
23. ROCH-RAMEL, F., GUISAN, B. AND SCHILD, L.: Indirect coupling of urate and p-aminohippurate transport to sodium in human brush-border membrane vesicles. Am. J. Physiol 270: F61-F68, 1996b.
24. ROCH-RAMEL, F., WERNER, D. AND GUISAN, B.: Urate transport in brush-border membrane of human kidney. Am. J. Physiol. 266: F797-F805, 1994.
25. SEGEL, I. H.: Biochemical Calculations, 2nd ed. John Wiley & Sons, New York, 1968.
26. SINCLAIR, D. S. AND Fox, I. H.: The pharmacology of hypouricemic effect of benzbromarone. J. Rheumatol. 2: 437-745, 1975.
27. STEELE, T. H. AND OPPENHEIMER, S.: Factors affecting urate excretion following diuretic administration in man. Am. J. Med. 47: 564-574, 1969.
28. STEELE, T. H. AND RIESELBACH, R. E.: Renal urate excretion in normal man. Nephron 14: 21-32, 1975.
29. WALTER-SACK, I., DE VRIES, J. X., ITTENSOHN, A., KOHLMEIER, M. AND WEBER, E.: Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone. Klin. Wochenschr. 66: 160-166, 1988.
30. WALTER-SACK, I., DE VRIES, J. X., VON BUBNOFF, A., PFEILSCHIFTER, V. AND RAEDSCH, R.: Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - Evidence for active benzbromarone metabolites? Eur. J. Med. Res. 1: 16-20, 1995.
31. WEINER, I. M. AND TINKER, J. P.: Pharmacology of pyrazinamide: metabolic and renal function studies related to the mechanism of drug-induced urate retention. J. Pharmacol. Exp. Ther. 180: 411-434, 1972.